This website uses cookies to enhance the user experience.
||
N

NATURE PHARMA NORGE AS925 924 512

Limited company
Bekkeveien 163 3173 VEAR, Norge

NATURE PHARMA NORGE AS

Operating
Handel innenfor helsekost- og naturprodukter, samt andre produkter/tjenester som står i naturlig forbindelse med dette, herunder deltakelse i andre selskaper.
Postordre-/internetthandel med helsekost.

Organization

Chairman of the board
Years since formation
6 years
since Nov 6, 2020
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
80,000
1 share class
Total number of shareholders
3
2 companies, 1 person

Financials

Total operating income 2025
79,260,862
NOK
Annual total result 2025
18,570,762
NOK
Total equity 2025
19,030,038
NOK
Last update: Apr 20, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman
50 %
indirectly
Board Member
50 %
directly 25.5 %
indirectly 24.5 %

Others

NameRoleShares
S
SYNEGA REGNSKAP AS
Accountant-
R
REVICOM AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Chairman
50 %
indirectly
Board Member
50 %
directly 25.5 %
indirectly 24.5 %
Last update: Aug 29, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
X
XPANDIR SCANDINAVIA AS
Ordinary shares
40,000
50 %
Ordinary shares
20,400
25.5 %
Y
YOU LEARN AS
Ordinary shares
19,600
24.5 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
79,260,862
45,881,556
28,066,598
8,852,524
2,391,953
Annual Total Result
18,570,762
6,393,987
3,499,739
460,470
44,793
Total assets
28,377,154
16,659,164
7,254,255
2,596,771
1,200,919
Total liabilities
9,347,118
6,199,888
3,188,966
2,031,222
1,095,840
Total equity
19,030,038
10,459,276
4,065,289
565,550
105,079

P&L

Year20252024202320222021
Total operating income
79,260,862
45,881,556
28,066,598
8,852,524
2,391,953
Total operating costs
55,928,054
37,860,896
23,558,957
8,183,436
2,309,651
Operating result
23,332,809
8,020,660
4,507,641
669,088
82,302
Financial income/costs
482,014
185,321
-125,073
-2,401
-383
Profit before tax
23,814,823
8,205,981
4,382,567
666,687
81,918
Total tax & extraordinary income/cost
5,244,061
1,811,994
882,828
206,217
37,125
Annual Total Result
18,570,762
6,393,987
3,499,739
460,470
44,793

Balance overview

Year20252024202320222021
Total fixed assets
101,200
1,562,625
58,641
0
0
Total current assets
28,275,954
15,096,539
7,195,614
2,596,771
1,200,919
Total assets
28,377,154
16,659,164
7,254,255
2,596,771
1,200,919
Short term debt
8,048,186
5,475,325
3,188,966
1,211,222
275,840
Long term debt
1,298,933
724,563
0
820,000
820,000
Total liabilities
9,347,118
6,199,888
3,188,966
2,031,222
1,095,840
Contributed capital
80,000
80,000
80,000
74,430
74,430
Retained earnings
18,950,038
10,379,276
3,985,289
491,120
30,649
Total equity
19,030,038
10,459,276
4,065,289
565,550
105,079
Total equity and liabilities
28,377,157
16,659,164
7,254,255
2,596,771
1,200,919

Classification

21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises